Leveraging polysaccharide-derived nanocarriers to open new horizons in oral vaccine activation.

After two weeks, all participants received a seasonal influenza vaccine.While the increases in antibody titres and seroprotection rates did not reach statistical significance overall, a clear positive trend was observed in the arabinoxylan (AX) group.

also in 111,027 other papers